Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Millward

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999
A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancerM Friedlander, M J Millward, D Bell, et al.
Australian and New Zealand Journal of Medicine|June 1, 1996
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer InstituteM J Millward, L K Webster, G C Toner, et al.
Journal of the National Cancer Institute|September 18, 1996
Cremophor pharmacokinetics in patients receiving 3-, 6-, and 24-hour infusions of paclitaxelD Rischin, L K Webster, M J Millward, et al.
British Journal of Cancer|March 1, 1995
The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancerM J Lind, L Gumbrell, B M Cantwell, et al.
British Journal of Cancer|May 6, 2008
Overexpression and altered glycosylation of MUC1 in malignant mesotheliomaJ Creaney, A Segal, G Sterrett, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancerM J Millward, D R Newell, K Yuen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Optimizing the erythromycin breath test for use in cancer patientsL P Rivory, K Slaviero, J P Seale, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481)M J Millward, D R Newell, V Mummaneni, et al.
Seminars in Oncology|October 1, 1994
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation studyA H Calvert, M J Lind, S Ghazal-Aswad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J F Bishop, M Friedlander, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 1999
A phase II study of gemcitabine in platinum pre-treated patients with advanced epithelial ovarian cancerM Friedlander, M J Millward, D Bell, et al.
Australian and New Zealand Journal of Medicine|June 1, 1996
Carboplatin dosing based on measurement of renal function--experience at the Peter MacCallum Cancer InstituteM J Millward, L K Webster, G C Toner, et al.
Journal of the National Cancer Institute|September 18, 1996
Cremophor pharmacokinetics in patients receiving 3-, 6-, and 24-hour infusions of paclitaxelD Rischin, L K Webster, M J Millward, et al.
British Journal of Cancer|March 1, 1995
The use of granulocyte colony-stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancerM J Lind, L Gumbrell, B M Cantwell, et al.
British Journal of Cancer|May 6, 2008
Overexpression and altered glycosylation of MUC1 in malignant mesotheliomaJ Creaney, A Segal, G Sterrett, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1995
Pharmacokinetics and pharmacodynamics of prolonged oral etoposide in women with metastatic breast cancerM J Millward, D R Newell, K Yuen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Optimizing the erythromycin breath test for use in cancer patientsL P Rivory, K Slaviero, J P Seale, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481)M J Millward, D R Newell, V Mummaneni, et al.
Seminars in Oncology|October 1, 1994
Carboplatin and granulocyte colony-stimulating factor as first-line treatment for epithelial ovarian cancer: a phase I dose-intensity escalation studyA H Calvert, M J Lind, S Ghazal-Aswad, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase II trial of a 3-hour infusion of paclitaxel in previously untreated patients with advanced non-small-cell lung cancerM J Millward, J F Bishop, M Friedlander, et al.
Pageof 6